0055dkk
37,5 %
Date:2025-04-03Time:12:45:17Latest report:Q2-2023List:First NorthTicker:BRAINP
Market Cap:32 mdkkEnterprise Value:27 mdkkNet Sales:2,95 mdkkEarnings:-11,6 mdkkEmployees:0ISIN:DK0061670205

Ratios

10-year key figure history for Brain+ turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Brain+ with index and moving average MA50 and MA200.

Stockprice:0,055
MA50:0,06
MA200:0,09
Price/MA200:-38,0 %
RSI (14):63,2
Price/MA50:-2,6 %

Description

Brain+ focus area is Alzheimer's disease and dementia. Brain+ try to restore patients’ independence and quality of life by treating and detecting cognitive decline in Alzheimer’s disease and dementia through digital means. Brain+ has developed a set of Digital Medicine technologies. These technologies, combined with a clinical pipeline.

Pharmaceuticals